Pear Therapeutics, Inc. — Form D
Pear Therapeutics, Inc. of BOSTON, MA, a company, filed a Form D exempt-offering notice with the SEC on 2019-01-04. The offering totals $65.0M, of which $64.3M was reported sold. Industry: Other Health Care.
Offering
- Filed: 2019-01-04
- Form: D
- Accession: 0001615898-19-000001
- Industry: Other Health Care
- Exemptions: 06b
- Total offering: $65.0M
- Amount sold: $64.3M
- Remaining: $655K
- Investors: 21
- Date of first sale: 2018-12-21
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-329643
Issuer
- Name: Pear Therapeutics, Inc.
- CIK: 0001615898
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2013
- Address: 200 STATE STREET, 13TH FLOOR, BOSTON, MA, 02109
- Phone: 6469322774
Officers, directors & promoters (18)
| Name | Role | Location |
|---|
| Hongjie Hu | Director | Boston, MA |
| Jeremy Gilbert | Executive Officer | Boston, MA |
| Alex Waldron | Executive Officer | New Haven, CT |
| Andrew J Schwab | Director | San Francisco, CA |
| Andrew Schwab | Director | BOSTON, MA |
| Corey McCann | Director | Boston, MA |
| Corey McCann | Executive Officer | Boston, MA |
| Zack Lynch | Director | San Francisco, CA |
| Elena Viboch | Director | Menlo Park, CA |
| Timothy Petersen | Director | Waltham, MA |
| Nancy Schlichting | Director | Boston, MA |
| Christopher Guiffre | Executive Officer | Boston, MA |
| Julia Strandberg | Executive Officer | Boston, MA |
| Yuri Maricich | Executive Officer | Boston, MA |
| Ronan O'Brien | Executive Officer | Boston, MA |
| Antoun Nabhan | Executive Officer | Boston, MA |
| Tim J Petersen | Director | Boston, MA |
| Zack J Lynch | Director | Boston, MA |
Other filings by this issuer (4)
More